SARC SARC Participant Login
 
 
Collaborating for a Cure.
 





 

 

 

 

Closed SARC Trials

Closed SARC Trials

SARC002: Phase III Randomized Trial of 120-minute infusion Gemcitabine v. 90-minute infusion Gemcitabine plus Docetaxal in unresectable Soft Tissue Sarcoma: A Multi-Disciplinary Trial of the North American Sarcoma Study Group of the Connective Tissue Oncology Society

PI: Robert Maki, MD PhD

Date Initiated: 1/2/2003

Date Terminated: 4/17/2007

 
Sitemap | Terms of Use | Contact Us SARC | 24 Frank Lloyd Wright Drive, Lobby A, Suite 3100 | Ann Arbor, MI 48106 | phone 734.930.7600 | fax 734.930.7557